Wyeth, Orchid Reach Deal In Effexor Patent Fight
Wyeth LLC on Thursday struck a licensing deal with generics maker Orchid Chemicals & Pharmaceuticals Ltd. over Effexor XR, resolving a patent dispute in New Jersey over the blockbuster antidepressant and...To view the full article, register now.
Already a subscriber? Click here to view full article